Bob Kerrey - Managing Director @ Allen & Company

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title Managing Director
Primary Organization
Allen & Company

Location New York, New York, United States
Regions Greater New York Area, East Coast, Northeastern US
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Bob Kerrey is the Managing Director at Allen & Company.

Personal Investments

Number of Investments

Bob Kerrey

invested in

Mendaera

obfuscation

. This investment -

Series A - Mendaera

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Mendaera	—	Series A - Mendaera	obfuscated obfuscation

Jobs

Number of Current Jobs

Bob Kerrey

is the

Managing Director

Allen & Company

Allen & Company Managing Director

Board and Advisor Roles

Number of Current Board & Advisor Roles

Bob Kerrey

holds

board and advisor roles including

Board Member

Resilience

Board Member

Intarcia Therapeutics

, and

Advisor

Minerva Project

Resilience Board MemberNov 2020
Intarcia Therapeutics Board MemberSep 19, 2017
Minerva Project AdvisorDec 1, 2011
Auris Health Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Charity Companies With Less Than $500M in Revenue (Top 10K)	17,953
Life Insurance Companies With More Than 50 Employees	15,687
Investment Banks with Investments in New York, New York	8,764
Early Stage Venture Investors Investment Banks	16,581
Charity Companies With Less Than $1B in Revenue (Top 10K)	17,938
Seed Stage Investors Investment Banks	32,981
Life Insurance Companies With More Than $1M in Revenue (Top 10K)	7,483
United States Investment Banks	22,371
Wealth Management Companies With More Than $10M in Revenue	14,231
Investment Banks with Investments in Northeastern US	9,028

Recent News and Activity

Number of News Articles

Funding Round•

Aug 17, 2023

Mendaera raised

obfuscation

from Allen & Company and 6 other investors

Discover more funding rounds

News•

Feb 7, 2020